ARCA biopharma Q1 EPS $(0.14) Down From $(0.09) YoY
Portfolio Pulse from Benzinga Newsdesk
ARCA biopharma (NASDAQ:ABIO) reported a Q1 EPS loss of $(0.14), a 55.56% increase in losses compared to $(0.09) per share from the same period last year.
April 25, 2024 | 8:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ARCA biopharma reported a significant increase in losses for Q1, with EPS at $(0.14) compared to $(0.09) last year.
The reported increase in losses for ARCA biopharma is a negative indicator for the company's financial health and could lead to a decrease in investor confidence, potentially impacting the stock price negatively in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100